ANAB · Anaptysbio, Inc · Executive Compensation
$46.71
-1.18 (-2.46%)
At close · Oct 7
Return incl. dividend (before tax)
Market Cap
$1.45B
Shares
29.10M
Volume · Oct 7
203.78K
Avg daily vol (3M)
575.48K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Daniel Faga | President and Chief Executive Officer and Director | $6,133,943 |
| Paul Lizzul | Chief Medical Officer | $2,365,377 |
| Dennis Mulroy | Chief Financial Officer | $2,007,927 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Daniel Faga | President and Chief Executive Officer and Director | $13,630,292 |
| Paul Lizzul | Chief Medical Officer | $4,583,508 |
| Dennis Mulroy | Chief Financial Officer | $3,238,907 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Daniel Faga | President and Chief Executive Officer and Director | $7,461,920 |
| Paul Lizzul | Chief Medical Officer | $2,441,117 |
| Eric Loumeau | Chief Legal Officer | $2,258,185 |
| Dennis Mulroy | Chief Financial Officer | $2,155,954 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Daniel Faga | President and Chief Executive Officer and Director | $24,440,350 |
| Eric Loumeau | Chief Legal Officer | $3,841,763 |
| Paul Lizzul | Chief Medical Officer | $3,812,528 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Hamza Suria | President, Chief Executive Officer and Director | $3,538,858 |
| Paul Lizzul | Chief Medical Officer | $1,699,078 |
| Eric Loumeau | Chief Operating Officer and General Counsel | $1,655,786 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Dennis Mulroy | Chief Financial Officer | $1,622,853 |
| Paul Lizzul | Chief Medical Officer | $1,578,719 |
| Hamza Suria | President, Chief Executive Officer and Director | $885,390 |
| Eric Loumeau | Chief Operating Officer and General Counsel | $725,338 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Hamza Suria | M.B.A. President, Chief Executive Officer and Director | $7,875,186 |
| Dominic G. Piscitelli | M.B.A., C.P.A. Former Chief Financial Officer | $1,855,658 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Hamza Suria | M.B.A. President, Chief Executive Officer and Director | $5,122,232 |
| Marco Londei | Former Chief Medical Officer | $2,513,740 |
| Eric Loumeau | Interim Chief Financial Officer and General Counsel | $2,165,031 |
| Dominic G. Piscitelli | M.B.A., C.P.A. Former Chief Financial Officer | $2,115,705 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Hamza Suria | M.B.A. President, Chief Executive Officer and Director | $4,016,438 |
| Dominic G. Piscitelli | M.B.A., C.P.A. Former Chief Financial Officer | $2,871,248 |
| Marco Londei | Former Chief Medical Officer | $2,150,857 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Owen Hughes | Class I director | Appointed | 2026-05-11 |
| Christopher M. Murphy | Chief Financial Officer | Appointed | 2026-05-11 |
| J. Anthony Ware | board of directors of the Company | Resigned | 2026-04-20 |
| Magda Marquet | board of directors of the Company | Resigned | 2026-04-20 |
| Rita Jain | board of directors of the Company | Resigned | 2026-04-20 |
| Dennis Fenton | board of directors of the Company | Resigned | 2026-04-20 |
| Susannah Gray | Board of Directors | Appointed | 2026-03-27 |
| Tony Ware | Board of Directors | Appointed | 2026-03-27 |
| Rita Jain | Board of Directors | Appointed | 2026-03-27 |
| Magda Marquet | Board of Directors | Appointed | 2026-03-27 |
| John Orwin | Board of Directors | Appointed | 2026-03-27 |
| John Schmid | Board of Directors | Appointed | 2026-03-27 |
| Dennis Fenton | Board of Directors | Appointed | 2026-03-27 |
| Daniel Faga | Board of Directors | Appointed | 2026-03-27 |
| Ajim Tamboli | Chief Financial Officer (CFO) | Appointed | 2026-03-27 |
| Daniel Faga | president and CEO of First Tracks Bio | Appointed | 2026-03-27 |
| Eric Loumeau | executive officer | Terminated | 2026-03-27 |
| Dennis Mulroy | executive officer | Terminated | 2026-03-27 |
| Susannah Gray | Class I director | Appointed | 2026-03-27 |
| John Orwin | Chairman of the Board | Appointed | 2023-09-18 |
| John Orwin | Class II director | Appointed | 2023-09-18 |
| James N. Topper, M.D., Ph.D. | Class II director | Resigned | 2023-09-18 |
| James N. Topper, M.D., Ph.D. | Chairman of the Board | Resigned | 2023-09-18 |
| Rita Jain, M.D. | Class II director | Appointed | 2023-04-06 |
| Laura J. Hamill | Class II director | Resigned | 2023-04-06 |